
    
      Estimated Enrollment: 354

      Study start date: October 2012

      Estimated Study Completion Date: October 2015

      Statin Group: Treatment with Atorvastatin 20mg daily after radical prostatectomy during 1
      year.

      Control Group: Treatment with Placebo daily after radical prostatectomy during 1 year.

      Follow up: every 3 months for the first year. Check PSA, Total/LDL-cholesterol and
      Triglyceride.

      Primary End Point Rate of Biochemical recurrence

      Secondary End Point Clinical progression of prostate cancer Change of Total/LDL- cholesterol
      and Triglycerides 5 year-Biochemical recurrence free survival
    
  